A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of Methotrexate

<p>Methotrexate (MTX) is a chemotherapeutic agent used in treatment of many disorders including autoimmune diseases and cancers. The availability of a reliable analysis method for drug assay in biological fluids of interest  is  a  prerequisite  for  all  pharmacokinetic  studies  in  humans ...

Full description

Bibliographic Details
Main Authors: Leila Pourtalebi Jahromi, Soliman Mohammadi-Samani, Hajar Ashrafi, Amir Azadi
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2016-06-01
Series:Trends in Pharmaceutical Sciences
Online Access:http://tips.sums.ac.ir/index.php/TiPS/article/view/71
id doaj-2eb32445fa7e447d9f040fb7d93092d6
record_format Article
spelling doaj-2eb32445fa7e447d9f040fb7d93092d62020-11-25T01:49:59ZengShiraz University of Medical SciencesTrends in Pharmaceutical Sciences2423-37222423-56522016-06-012210.1111/tips.v2i2.7150A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of MethotrexateLeila Pourtalebi Jahromi0Soliman Mohammadi-Samani1Hajar Ashrafi2Amir Azadi3Pharmaceutical Science Research Center, Shiraz University of Medical Sciences, Shiraz, IranPharmaceutical Science Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. and Department of Pharmaceutics, School of Pharmacy, International branch, Shiraz University of Medical Sciences, Shiraz, IranPharmaceutical Science Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.<p>Methotrexate (MTX) is a chemotherapeutic agent used in treatment of many disorders including autoimmune diseases and cancers. The availability of a reliable analysis method for drug assay in biological fluids of interest  is  a  prerequisite  for  all  pharmacokinetic  studies  in  humans  or  animal  models. Considering the complex matrices of the biological specimens as well as the low concentrations of the majority of the drugs in biological fluids, the development of an available while sensitive method for the bioanalytical studies is often a challenging issue.</p><p>For drug assay in aqueous, plasma, animal brain and liver tissue environments in a concentration range of 25-600 ng/ml, a reverse phase high performance liquid chromatography (RP-HPLC) was developed.</p><p>System suitability tests were indicating a method with acceptable analytic separation efficiency and peak shape proving method’s selectivity. Limit of detection (LOD) and limit of quantification (LOQ) determined to be 10 ng/ml and 25ng/ml, which reflect method sensitivity. Regression analysis showed a linear correlation between area under curve (AUC) of peaks and corresponding MTX concentrations. The within-day and between-day precision and accuracy was both in acceptable ranges. Recovery index of method for median concentration (200 ng/ml) is also about 74%.</p><p>The developed method was accorded to the acceptable criteria of analytical method validation. The sensitivity of the method in all the tested matrices made the method suitable in terms of detection and quantitation of low concentration samples throughout the study. Also, the assay method had fairly short run-time and lacks any significant interference. </p>http://tips.sums.ac.ir/index.php/TiPS/article/view/71
collection DOAJ
language English
format Article
sources DOAJ
author Leila Pourtalebi Jahromi
Soliman Mohammadi-Samani
Hajar Ashrafi
Amir Azadi
spellingShingle Leila Pourtalebi Jahromi
Soliman Mohammadi-Samani
Hajar Ashrafi
Amir Azadi
A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of Methotrexate
Trends in Pharmaceutical Sciences
author_facet Leila Pourtalebi Jahromi
Soliman Mohammadi-Samani
Hajar Ashrafi
Amir Azadi
author_sort Leila Pourtalebi Jahromi
title A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of Methotrexate
title_short A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of Methotrexate
title_full A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of Methotrexate
title_fullStr A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of Methotrexate
title_full_unstemmed A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of Methotrexate
title_sort reversed-phase high performance liquid chromatography (hplc) method for bio-analysis of methotrexate
publisher Shiraz University of Medical Sciences
series Trends in Pharmaceutical Sciences
issn 2423-3722
2423-5652
publishDate 2016-06-01
description <p>Methotrexate (MTX) is a chemotherapeutic agent used in treatment of many disorders including autoimmune diseases and cancers. The availability of a reliable analysis method for drug assay in biological fluids of interest  is  a  prerequisite  for  all  pharmacokinetic  studies  in  humans  or  animal  models. Considering the complex matrices of the biological specimens as well as the low concentrations of the majority of the drugs in biological fluids, the development of an available while sensitive method for the bioanalytical studies is often a challenging issue.</p><p>For drug assay in aqueous, plasma, animal brain and liver tissue environments in a concentration range of 25-600 ng/ml, a reverse phase high performance liquid chromatography (RP-HPLC) was developed.</p><p>System suitability tests were indicating a method with acceptable analytic separation efficiency and peak shape proving method’s selectivity. Limit of detection (LOD) and limit of quantification (LOQ) determined to be 10 ng/ml and 25ng/ml, which reflect method sensitivity. Regression analysis showed a linear correlation between area under curve (AUC) of peaks and corresponding MTX concentrations. The within-day and between-day precision and accuracy was both in acceptable ranges. Recovery index of method for median concentration (200 ng/ml) is also about 74%.</p><p>The developed method was accorded to the acceptable criteria of analytical method validation. The sensitivity of the method in all the tested matrices made the method suitable in terms of detection and quantitation of low concentration samples throughout the study. Also, the assay method had fairly short run-time and lacks any significant interference. </p>
url http://tips.sums.ac.ir/index.php/TiPS/article/view/71
work_keys_str_mv AT leilapourtalebijahromi areversedphasehighperformanceliquidchromatographyhplcmethodforbioanalysisofmethotrexate
AT solimanmohammadisamani areversedphasehighperformanceliquidchromatographyhplcmethodforbioanalysisofmethotrexate
AT hajarashrafi areversedphasehighperformanceliquidchromatographyhplcmethodforbioanalysisofmethotrexate
AT amirazadi areversedphasehighperformanceliquidchromatographyhplcmethodforbioanalysisofmethotrexate
AT leilapourtalebijahromi reversedphasehighperformanceliquidchromatographyhplcmethodforbioanalysisofmethotrexate
AT solimanmohammadisamani reversedphasehighperformanceliquidchromatographyhplcmethodforbioanalysisofmethotrexate
AT hajarashrafi reversedphasehighperformanceliquidchromatographyhplcmethodforbioanalysisofmethotrexate
AT amirazadi reversedphasehighperformanceliquidchromatographyhplcmethodforbioanalysisofmethotrexate
_version_ 1725003535472394240